These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3825212)

  • 1. [Behavior of so-called cardiovascular risk factors in general practice cardiac therapy--results of selected biochemical parameters of probands with suspect cardiovascular findings in a follow-up program of a 5-year intervention study].
    Richter K; Hempel WE; Gerhard W; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Nov; 41(21):598-602. PubMed ID: 3825212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavior of biochemical parameters in probands with suspect cardiovascular findings in relation to age and sex. Studies of a representative sample following roentgen image screening (the Berlin cardiac detection and monitoring model)].
    Gerhard W; Hempel WE; Richter K; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1985 Nov; 40(21):619-24. PubMed ID: 4090551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of cardiovascular risk factors in patients after coronary artery bypass grafting with an in-hospital rehabilitation programme (WHO Stage I of Rehabilitation): 1-year follow-up].
    Schimmer C; Krannich JH; Brauchle-Hopp U; Elert O
    Rehabilitation (Stuttg); 2006 Apr; 45(2):95-101. PubMed ID: 16575715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
    Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
    Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).
    Yamada C; Johnson JA; Robertson P; Pearson G; Tsuyuki RT
    Pharmacotherapy; 2005 Jan; 25(1):110-5. PubMed ID: 15767226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation].
    Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1525-30. PubMed ID: 12854061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of measurements of cholesterol, glucose and uric acid taken at 5-year intervals in children and adolescents].
    Spyckerelle Y; Steinmetz J; Deschamps JP
    Arch Fr Pediatr; 1992 Dec; 49(10):875-81. PubMed ID: 1304153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of laboratory diagnostic study parameters of the hepatobiliary system in the evaluation of cardiovascular diseases--results of cross sectional and longitudinal studies in patients with suspicious cardiovascular findings in an epidemiologic follow-up study].
    Richter K; Hempel WE; Gerhard W; Vogelreuter K; Wagenknecht CU
    Z Gesamte Inn Med; 1986 Aug; 41(15):413-8. PubMed ID: 3490068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of blood uric acid with other cardiovascular risk factors in the male working population in Valencia].
    Corella D; Silla J; Ordovás JM; Sabater A; Ruiz de la Fuente S; Portolés O; González JI; Saiz C
    Rev Clin Esp; 1999 Dec; 199(12):806-12. PubMed ID: 10687413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of pathologic laboratory values in patients with cardiovascular diseases--consequences for diagnosis in general practice].
    Gerhard W; Hempel WE; Gaber E; Richter K; Wagenknecht CU
    Z Gesamte Inn Med; 1987 Dec; 42(23):670-3. PubMed ID: 3445649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study.
    Kaitosaari T; Rönnemaa T; Raitakari O; Talvia S; Kallio K; Volanen I; Leino A; Jokinen E; Välimäki I; Viikari J; Simell O
    Circulation; 2003 Aug; 108(6):672-7. PubMed ID: 12885748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.